NYSE:MMS
NYSE:MMSProfessional Services

Assessing Maximus (MMS) Valuation After Recent Pullback And Ongoing Share Price Momentum

Assessing Maximus after recent share price moves Maximus (MMS) has seen a mix of short term moves, with a 1 day return near flat, a negative week, and stronger month and past 3 months performance. The stock recently closed at $94.44. See our latest analysis for Maximus. That recent pullback over the week comes after a steady stretch, with a 30 day share price return of 9.22% and a 1 year total shareholder return of 27.43%, suggesting momentum has generally been positive over the past year. If...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

Cimpress (CMPR) Valuation Check After Q2 2026 Beat And Upgraded 2026 Guidance

Cimpress (CMPR) pushed past US$1b in quarterly revenue in Q2 2026, raised its 2026 guidance for revenue, adjusted EBITDA and free cash flow, and reiterated confidence in its longer term 2028 financial targets. See our latest analysis for Cimpress. The guidance upgrade and first ever US$1b quarter have come alongside a 20.5% 1 month share price return and a 16.1% 3 month share price return. The 3 year total shareholder return of 116.4% contrasts with a 5 year total shareholder return decline...
NYSE:EAT
NYSE:EATHospitality

A Look At Brinker International (EAT) Valuation After Earnings Beat And Upgraded Full Year Guidance

Why Brinker's latest quarter matters for investors Brinker International (EAT) just posted fiscal second quarter results that topped analyst estimates and lifted full year earnings and revenue guidance, putting the spotlight on Chili's same store sales trends and restaurant level execution. See our latest analysis for Brinker International. At a share price of US$157.72, Brinker has had a 90 day share price return of 50.14% and a 3 year total shareholder return of about 3x, suggesting...
NasdaqGS:FA
NasdaqGS:FAProfessional Services

How a Board Exit and Stake Cut at First Advantage (FA) Has Changed Its Investment Story

On January 29, 2026, First Advantage Corporation announced that Board member Bianca Stoica resigned from the Board and its Compensation Committee, with the company stating her departure was not related to any disagreement over operations, policies, or practices. Her exit comes as investors are already focused on First Advantage’s response to AI-driven disruption in employment services and a major shareholder’s recent decision to reduce its stake. Against this backdrop, we will explore how...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

How Raymond James’ Power-Solutions Upgrade Will Impact Flex’s (FLEX) Data Center Profit Mix

Raymond James recently upgraded its rating on Flex Ltd., highlighting the company’s differentiated power solutions for hyperscale data centers within the cloud and AI infrastructure space. The focus on higher-margin power offerings suggests that Flex’s expanding role in data center infrastructure could meaningfully influence its overall profitability mix. Next, we’ll explore how this upbeat view on Flex’s cloud and AI power solutions shapes the company’s broader investment narrative. AI is...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

Assessing Tetra Tech (TTEK) Valuation After Earnings Beat Guidance Lift And Major Defense Wins

Earnings beat, guidance update and new contracts Tetra Tech (TTEK) recently reported quarterly earnings and revenue above analyst estimates, lifted its full year net revenue guidance, and secured a long term U.S. Missile Defense Agency SHIELD contract alongside two defense focused consulting acquisitions. At the same time, the company increased its dividend and continued share repurchases. These moves, together with higher margin advisory work and international contributions, are shaping how...
NasdaqGS:CVCO
NasdaqGS:CVCOConsumer Durables

Assessing Cavco Industries (CVCO) Valuation After The Recent Share Price Pullback

What Cavco Industries stock’s recent pullback means for investors Cavco Industries (CVCO) has pulled back recently, with the share price showing negative returns over the past week, month, and past 3 months. This has prompted a closer look at how the business is currently positioned. See our latest analysis for Cavco Industries. The recent 1 day share price decline of 20.32%, following a 7 day share price return of 26.27% and a 30 day share price return of 16.83%, has sharply reversed earlier...
NasdaqGS:PEBO
NasdaqGS:PEBOBanks

Peoples Bancorp (PEBO) Valuation Check After Earnings Growth And Margin Expansion

Peoples Bancorp (PEBO) has drawn fresh attention after reporting fourth quarter 2025 results, including higher net interest income, an 86.4% rise in net earnings, and an affirmed quarterly cash dividend of $0.41 per share. See our latest analysis for Peoples Bancorp. The recent earnings beat and dividend affirmation have come alongside a 90 day share price return of 12.76% and a 1 year total shareholder return of 5.25%. The 3 year total shareholder return of 25.08% points to steadier gains...
NYSE:AFL
NYSE:AFLInsurance

Is Aflac (AFL) Attractively Priced After Strong Multi Year Share Price Performance

If you are wondering whether Aflac's current share price reflects its real worth, you are not alone. This article focuses squarely on what you are getting for the price you pay. Aflac last closed at US$110.95, with returns of 3.6% over the past 7 days, 0.6% over 30 days, 0.6% year to date, 5.6% over 1 year, 70.8% over 3 years and 174.2% over 5 years. Recent attention on Aflac has been shaped by ongoing coverage of its role in the insurance sector and discussion around how its long term share...
NYSE:LEVI
NYSE:LEVILuxury

Levi Strauss Refocuses On Core Brands With DTC And AI Push

Levi Strauss (NYSE:LEVI) is reshaping its business, discontinuing the Denizen brand and preparing to sell Dockers. The company is accelerating a direct to consumer first approach while expanding its Beyond Yoga segment. Levi Strauss is also increasing its use of artificial intelligence across operations and customer engagement. Levi Strauss, trading at $19.88, is making several material changes at once that go well beyond tweaking a single brand or product line. The stock is up 7.5% over...
NYSE:BMY
NYSE:BMYPharmaceuticals

How Investors May Respond To Bristol Myers Squibb (BMY) Expanding AI-Enabled Oncology Partnerships

Janux Therapeutics announced in January 2026 that it had entered a collaboration and exclusive worldwide license agreement with Bristol Myers Squibb to develop a novel tumor-activated solid-tumor therapy, potentially worth up to US$850 million in upfront, near-term, and milestone payments plus tiered royalties. In parallel, Bristol Myers Squibb’s recent AI-focused partnership with Microsoft on early lung cancer detection highlights how the company is pairing oncology drug development with...
NYSE:GPN
NYSE:GPNDiversified Financial

Global Payments Reshapes Portfolio With Issuer Sale And Worldpay Deal

Global Payments (NYSE:GPN) is selling its issuer processing business in a major reshaping of its operations. The company is also acquiring Worldpay, aiming to combine the two payments platforms. Management is targeting substantial operational synergies from these moves, indicating a major restructuring of how the business is run. Global Payments, trading at $71.74, has seen sizable pressure on its share price, with a 1 year return of a 35.7% decline and a 5 year return of a 62.2% decline...
NYSE:GAP
NYSE:GAPSpecialty Retail

Gap (GPS) Valuation Check After Q3 Beat And Ongoing Analyst Upgrades

Gap (GAP) is back in focus after reporting Q3 revenue growth of 3% year on year, beating analyst expectations on sales, EBITDA and gross margin, and posting a seventh consecutive quarter of positive comparable sales. See our latest analysis for Gap. The recent Q3 beat and a series of upbeat analyst updates have coincided with a 22.67% 90 day share price return and a 104.70% three year total shareholder return, signalling firm momentum from short term traders and longer term holders alike. If...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

The Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following First Dual-Gene RNAi Cardio Trial Initiation

Arrowhead Pharmaceuticals recently dosed the first subjects in a Phase 1/2a trial of ARO-DIMER-PA, an RNAi therapeutic targeting atherosclerotic cardiovascular disease caused by mixed hyperlipidemia by silencing PCSK9 and APOC3. This is the first clinical RNAi candidate designed to simultaneously target two genes in a single molecule, highlighting a new approach to treating residual cardiovascular risk in patients with elevated LDL cholesterol and triglycerides. We will now explore how this...
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources Q1 Net Inflows Challenge Bearish Narratives On AUM Pressure

Franklin Resources (BEN) opened fiscal 2026 with Q1 revenue of US$2.3 billion and basic EPS of US$0.49, alongside net income of US$255.5 million and trailing twelve month EPS of US$1.09. This sets a clear marker for how the year is starting to shape up. Over recent periods, revenue has moved from US$2.2 billion in Q4 2024 to US$2.1 billion in Q2 2025, US$2.1 billion in Q3 2025, US$2.3 billion in Q4 2025 and now US$2.3 billion in Q1 2026, while quarterly EPS has ranged from a loss of US$0.18...
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Is Sonos (SONO) Pricing Too Rich After Mixed Long Term Share Performance

If you are looking at Sonos and wondering whether the current share price gives you good value, you are not alone. This article will walk through what that price really reflects. Sonos shares last closed at US$14.35, with returns of a 3.8% decline over 7 days, an 18.0% decline over 30 days, an 18.0% decline year to date, a 4.1% gain over 1 year, a 24.1% decline over 3 years, and a 53.7% decline over 5 years. These mixed returns have put a spotlight on what might be driving the share price,...
NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies Balances Record Safety, Growth Investments And Talc Litigation Costs

Minerals Technologies reported a record company safety performance in 2025, setting a new benchmark for its operations. The company increased investment in growth platforms across pet litter, edible oil purification, and paper and packaging in key global markets. Engineered Solutions delivered record profitability in a challenging market, while Minerals Technologies continued to incur talc related litigation costs. For investors tracking NYSE:MTX, the recent news adds important context to a...
NYSE:AIR
NYSE:AIRAerospace & Defense

AAR Expansion With Alaska Airlines Highlights Long Term MRO Growth Story

AAR Corp. (NYSE:AIR) has substantially completed a major expansion of its Airframe MRO facility in Oklahoma City. The project adds significant maintenance capacity, including high-demand airframe MRO bays. The expansion is paired with a long-term collaboration with Alaska Airlines for airframe maintenance services. The company plans to create 200 new jobs tied to the enlarged facility. AAR is also moving toward more digitized maintenance processes as part of the expansion. AAR Corp...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

F5 Breach Lawsuits Test Security Credibility And Growth Story For Investors

F5 is facing ongoing investigations and class action lawsuits tied to a long term nation state breach involving its BIG-IP products. Plaintiffs allege that management misled investors about the company’s security posture and the scope and impact of the cyber incident. The situation raises questions about disclosure practices, potential legal liabilities, and future regulatory scrutiny for NasdaqGS:FFIV. For investors tracking NasdaqGS:FFIV, this comes at a time when the stock trades around...
NYSE:CRM
NYSE:CRMSoftware

Salesforce Extends AI Reach Into Defense And Critical Infrastructure Workloads

Salesforce (NYSE:CRM) secured a US$5.6b, 10-year modernization contract with the U.S. Army focused on secure, AI-driven cloud solutions. The company also joined a consortium with Lockheed Martin and PG&E to launch EMBERPOINT, an AI-powered wildfire detection and prevention venture. Both moves expand Salesforce's presence in national security and critical infrastructure use cases beyond its core CRM offerings. For you as an investor, these announcements show Salesforce pushing deeper into...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

A Look At Nutanix (NTNX) Valuation After Dual Analyst Downgrades On Growth Concerns

Why Nutanix Is Back in Focus After Dual Analyst Downgrades Barclays and Morgan Stanley both downgraded Nutanix (NTNX), pointing to slowing growth, limited momentum, and weaker visibility into revenue, a combination that has sharpened investor attention on the stock’s recent pullback. See our latest analysis for Nutanix. The recent analyst downgrades arrived after a sharp swing in sentiment, with Nutanix’s share price at US$39.33 and a 30 day share price return of a 22.27% decline, adding to a...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Is Dave (DAVE) Using Boardroom AI Expertise to Reinforce Its Fintech Innovation Story?

Dave Inc. recently announced that Nima Khajehnouri, a veteran artificial intelligence and data engineering leader with senior roles at Meta, Google, and Snap, has joined its Board of Directors and Audit Committee, while Imran Khan has stepped down and several board leadership roles have shifted. This appointment underscores Dave’s push to deepen its technical governance as it continues deploying disruptive technologies to support its financial services platform for millions of Americans...
NYSE:CRH
NYSE:CRHBasic Materials

CRH (NYSE:CRH) Valuation Check As Buybacks, Institutional Buying And Analyst Revisions Refocus Attention

Why CRH (NYSE:CRH) is back on investors’ radar CRH (NYSE:CRH) is drawing fresh attention after a series of share repurchases under its $300 million buyback programme, combined with larger positions from institutional investors and active analyst rating revisions. See our latest analysis for CRH. Despite the recent buybacks and institutional buying, CRH’s recent share price performance has cooled a little, with a 30 day share price return showing a 3.2% decline and a 90 day gain of 3.4%, while...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

A Look At iRhythm Holdings (IRTC) Valuation After Recent Share Price Volatility

What iRhythm’s recent performance means for investors iRhythm Holdings (IRTC) has drawn fresh attention after a mixed stretch in its share performance, with a gain of 3.7% over the past day contrasted against negative returns over the past week, month, and past 3 months. For investors, that combination of short term strength and recent weakness raises questions about how the current US$154.51 share price lines up with the company’s business profile, financial results, and longer term track...